Loading interface...

Istavel 100 mg Tablet

Manufactured bySun Pharma Laboratories Ltd.
ContainsSitagliptin
Description

Istavel 100 mg Tablet is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adult patients. Patients are advised to follow a strict diet and exercise regimen along with this medicine for the best possible effect. This medicine is not recommended for use in patients with type 1 diabetes and diabetic ketoacidosis.

Side effects

Major & minor side effects for Istavel 100 mg Tablet

  • Anxiety
  • Headache
  • Chills
  • Blurred vision
  • Confusion
  • Nausea
  • Cough
  • Fever
  • Sore throat

Uses of Istavel 100 mg Tablet

What is it prescribed for?

  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The peak effect of this medicine can be observed after 1-4 hours of administration.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.

Allergy

This medicine is not recommended for use in patients with a known allergy to sitagliptin.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.
General warnings

Use in children

This medicine is not recommended for use in children and adolescents.

Bullous pemphigoid

This medicine should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

Diabetic ketoacidosis

This medicine is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient's condition.

Type 1 diabetes mellitus

This medicine is not recommended for use in patients with type 1 diabetes mellitus.

Missed Dose

Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine

Clozapine

Acetazolamide

Gatifloxacin

Benazepril

Bexarotene

Bumetanide

Disease interactions

Pancreatitis

This medicine should be used with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis. Report any symptoms such as abdominal pain, nausea, vomiting, etc. to the doctor immediately. Therapy with the medicine may be discontinued based on the clinical condition of the patient.

Renal Dysfunction

This medicine should be used with extreme caution in patients with a history of kidney diseases due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments should be done based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Istavel 100 mg Tablet with or without food. Do not crush or chew the tablet. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Istavel 100 mg Tablet increases insulin and lowers glucagon production. This results in lowering of the blood glucose levels.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Dipeptidyl peptidase 4 inhibitors

Schedule

Schedule H

DailyMed - JANUVIA- sitagliptin tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 21 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f85a48d0-0407-4c50-b0fa-7673a160bf01

EMC [Internet]. 2017 [cited 21 August 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/19610

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 21 August 2017]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database

Sitagliptin - DrugBank [Internet]. Drugbank.ca. 2017 [cited 21 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB01261

Sitagliptin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 21 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a606023.html

TOXNET [Internet]. Toxnet.nlm.nih.gov. 2017 [cited 21 August 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 30 Oct 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.